Opus Genetics, Inc. (NASDAQ:IRD), a pharmaceutical preparations company with a market capitalization of $36.3 million, has updated its executive employment agreements, enhancing severance terms for ...

Submission supported by positive results from global, Phase 3 4WHIM clinical trial;U.S. regulatory approval in WHIM syndrome granted in ...

CEO of Dr Reddy's Laboratories, Erez Israeli believes his company's affordable medicines benefit the U.S. market and will be ...

The agreement, announced Thursday, would require the Sackler family to pay $6.5 billion over the next 15 years and an additional nearly $900 million from Purdue Pharma following its emergence from ...

Since its creation by a team of pharmaceutical, cold-chain management and quality assurance experts in 2004, Sentry BioPharma ...

We recently published a list of 12 High Growth International Stocks to Invest in Now. In this article, we are going to take a ...

Min Son of Hanol IP & Law says pharmaceutical R&D in South Korea should be enhanced on the introduction of a clearer legal framework that offers improved market protection for new and modified drugs ...

Not for Dissemination in the US or through US Newswire ServicesTORONTO, Jan. 21, 2025 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its ...

Our latest edition explores the top merger control trends across the EU, US, UK, Middle East and Australia, and the outlook for 2025.

This international initiative unites academic students, postgraduates and young professionals in a unique program designed to ...